Scholars Central

Review articlePublished 6 Sep 2016

Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous Coronary Intervention

Authors: Shabnam Rashid

Archives of Medicine

Volume 8 · Issue 5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In patients who have had percutaneous coronary intervention for acute coronary syndromes or stable angina dual antiplatelet therapy is required. If there is a history of atrial fibrillation, thrombosis or presence of a mechanical heart valve then long term anticoagulation may be necessary. However, the use of antiplatelets with anticoagulation increases the risk of bleeding. The need for anticoagulation in such patients needs to be carefully assessed by taking into account the risk of bleeding with anticoagulation and the risk of thromboembolic events without anticoagulation. If triple therapy is required then the shortest duration of treatment should be prescribed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Archives of Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives of Medicine
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Shabnam Rashid”